Article info

PDF

A metabolomics-based biomarker signature discriminates pancreatic cancer from chronic pancreatitis

Authors

  1. Correspondence to Professor Eithne Costello, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, 2nd Floor Sherrington Building, Ashton Street, Liverpool L69 3GE, UK; ecostell{at}liverpool.ac.uk
View Full Text

Citation

Costello E
A metabolomics-based biomarker signature discriminates pancreatic cancer from chronic pancreatitis

Publication history

  • Received February 8, 2017
  • Revised April 10, 2017
  • Accepted April 11, 2017
  • First published May 24, 2017.
Online issue publication 
December 12, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.